Intellia Therapeutics Inc. (NTLA) NASDAQ

$43.81 0.90 (2.10%)

Market Cap: $3.32B

As of 05/25/22 04:00 PM EDT. Market closed.

(NTLA)

Intellia Therapeutics Inc. (NTLA) NASDAQ

$43.81 0.90 (2.10%)

Market Cap: $3.32B

As of 05/25/22 04:00 PM EDT. Market closed.

Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single ... read more

Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Leonard
Full Time Employees
211
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$9.71M
URL
Address
40 Erie St Ste 130, Massachusetts, Cambridge, 02139-4254.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Leonard
Full Time Employees
211
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$9.71M
Address
40 Erie St Ste 130, Massachusetts, Cambridge, 02139-4254.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$42.81
Previous Close
$42.91
Days Range
$41.62 - $45.14
52 week range
$38.85 - $202.73
Volume
839,815
Avg. Volume (30 days)
1,199,328
Market Cap
$3.32B
Dividend Yield
0.00%
P/E
-9.02
Shares Outstanding
75,853,870
Open
$42.81
Previous Close
$42.91
Days Range
$41.62 - $45.14
52 week range
$38.85 - $202.73
Volume
839,815
Avg. Volume (30 days)
1,199,328
Market Cap
$3.32B
Dividend Yield
0.00%
P/E
-9.02
Shares Outstanding
75,853,870

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INTELLIA THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
LEONARD JOHN M President and CEO Jan 01, 2022 Sale $112.25 2,493 279,852 724,660 Mar 04, 2022, 09:07 PM
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Jan 01, 2022 Sale $112.25 1,148 128,863 4,815 Mar 03, 2022, 08:03 PM
Lebwohl David EVP, Chief Medical Officer Jan 01, 2022 Sale $112.24 1,051 117,964 10,922 Mar 03, 2022, 08:00 PM
Goddard Glenn EVP, Chief Financial Officer Jan 01, 2022 Sale $112.24 1,013 113,699 2,049 Mar 03, 2022, 07:38 PM
Lebwohl David EVP, Chief Medical Officer Nov 05, 2021 Option Exercise $12.62 2,400 30,288 11,114 Nov 09, 2021, 06:08 PM
Lebwohl David EVP, Chief Medical Officer Nov 05, 2021 Sale $132.72 2,400 318,535 9,914 Nov 09, 2021, 06:08 PM
Lebwohl David EVP, Chief Medical Officer Oct 14, 2021 Option Exercise $12.62 2,400 30,288 11,114 Oct 15, 2021, 07:02 PM
Lebwohl David EVP, Chief Medical Officer Oct 14, 2021 Sale $128.44 2,400 308,249 10,563 Oct 15, 2021, 07:02 PM
Crowley John F Director Oct 11, 2021 Option Exercise $18.83 2,500 47,075 4,594 Oct 13, 2021, 04:15 PM
Crowley John F Director Oct 11, 2021 Sale $119.55 2,500 298,875 2,094 Oct 13, 2021, 04:15 PM
Crowley John F Director Oct 05, 2021 Option Exercise $18.83 10,000 188,300 12,094 Oct 07, 2021, 05:41 PM
Crowley John F Director Oct 05, 2021 Sale $130.54 10,000 1,305,391 10,814 Oct 07, 2021, 05:41 PM
Lebwohl David EVP, Chief Medical Officer Sep 24, 2021 Option Exercise $12.62 7,923 99,988 8,714 Sep 27, 2021, 04:15 PM
Lebwohl David EVP, Chief Medical Officer Sep 21, 2021 Option Exercise $12.62 2,400 30,288 3,191 Sep 23, 2021, 05:48 PM
Lebwohl David EVP, Chief Medical Officer Sep 21, 2021 Sale $149.81 2,400 359,544 791 Sep 23, 2021, 05:48 PM
Goddard Glenn EVP, Chief Financial Officer Sep 07, 2021 Option Exercise $14.58 3,482 50,768 3,482 Sep 09, 2021, 05:38 PM
Goddard Glenn EVP, Chief Financial Officer Sep 07, 2021 Sale $180.12 3,482 627,178 0 Sep 09, 2021, 05:38 PM
LEONARD JOHN M President and CEO Aug 31, 2021 Option Exercise $14.58 37,833 551,605 757,138 Sep 01, 2021, 08:21 PM
LEONARD JOHN M President and CEO Aug 30, 2021 Option Exercise $14.23 38,804 552,031 758,109 Sep 01, 2021, 08:21 PM
LEONARD JOHN M President and CEO Sep 01, 2021 Option Exercise $21.62 44,735 967,000 764,040 Sep 01, 2021, 08:21 PM
LEONARD JOHN M President and CEO Aug 31, 2021 Sale $155.00 37,833 5,864,115 719,305 Sep 01, 2021, 08:21 PM
LEONARD JOHN M President and CEO Aug 30, 2021 Sale $155.95 38,804 6,051,353 756,054 Sep 01, 2021, 08:21 PM
LEONARD JOHN M President and CEO Sep 01, 2021 Sale $170.00 44,735 7,604,950 719,305 Sep 01, 2021, 08:21 PM
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Aug 30, 2021 Option Exercise $14.01 97,000 1,359,300 99,391 Sep 01, 2021, 07:34 PM
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Aug 30, 2021 Sale $154.83 97,000 15,018,055 83,552 Sep 01, 2021, 07:34 PM
Lebwohl David EVP, Chief Medical Officer Aug 30, 2021 Option Exercise $12.62 2,400 30,288 3,191 Sep 01, 2021, 07:32 PM
Lebwohl David EVP, Chief Medical Officer Aug 30, 2021 Sale $158.04 2,400 379,300 2,991 Sep 01, 2021, 07:32 PM
Goddard Glenn EVP, Chief Financial Officer Aug 30, 2021 Option Exercise $19.27 5,200 100,204 5,200 Sep 01, 2021, 07:30 PM
Goddard Glenn EVP, Chief Financial Officer Aug 31, 2021 Option Exercise $18.93 24,800 469,374 24,800 Sep 01, 2021, 07:30 PM
Goddard Glenn EVP, Chief Financial Officer Aug 30, 2021 Sale $155.78 5,200 810,082 4,496 Sep 01, 2021, 07:30 PM
Goddard Glenn EVP, Chief Financial Officer Aug 31, 2021 Sale $160.22 24,800 3,973,456 0 Sep 01, 2021, 07:30 PM
LEONARD JOHN M President and CEO Aug 23, 2021 Option Exercise $13.40 27,139 363,663 746,444 Aug 25, 2021, 04:14 PM
LEONARD JOHN M President and CEO Aug 23, 2021 Sale $152.01 27,139 4,125,416 727,570 Aug 25, 2021, 04:14 PM
LEONARD JOHN M President and CEO Aug 19, 2021 Option Exercise $13.40 22,682 303,939 741,987 Aug 20, 2021, 06:14 PM
LEONARD JOHN M President and CEO Aug 19, 2021 Sale $151.28 22,682 3,431,398 732,261 Aug 20, 2021, 06:14 PM
Lebwohl David EVP, Chief Medical Officer Aug 09, 2021 Option Exercise $12.62 2,400 30,288 3,191 Aug 11, 2021, 04:50 PM
Lebwohl David EVP, Chief Medical Officer Aug 09, 2021 Sale $164.05 2,400 393,720 791 Aug 11, 2021, 04:50 PM
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Aug 04, 2021 Option Exercise $13.40 26,000 348,400 28,391 Aug 06, 2021, 06:19 PM
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Aug 04, 2021 Sale $138.24 26,000 3,594,357 26,920 Aug 06, 2021, 06:19 PM
Goddard Glenn EVP, Chief Financial Officer Aug 05, 2021 Option Exercise $19.27 20,000 385,400 20,000 Aug 06, 2021, 06:17 PM
Goddard Glenn EVP, Chief Financial Officer Aug 05, 2021 Sale $151.05 20,000 3,021,056 10,098 Aug 06, 2021, 06:17 PM
FORMELA JEAN FRANCOIS Director Apr 29, 2021 Sale $85.43 4,513 385,546 765,101 Apr 30, 2021, 08:55 PM
FORMELA JEAN FRANCOIS Director Apr 28, 2021 Sale $85.56 131,926 11,287,893 799,354 Apr 28, 2021, 07:51 PM
FORMELA JEAN FRANCOIS Director Apr 27, 2021 Sale $86.22 210,230 18,125,992 1,032,056 Apr 28, 2021, 07:51 PM
FORMELA JEAN FRANCOIS Director Apr 26, 2021 Sale $84.93 806 68,454 1,111,770 Apr 28, 2021, 07:51 PM
LEONARD JOHN M President and CEO Apr 13, 2021 Option Exercise $11.16 25,937 289,506 719,305 Apr 15, 2021, 08:50 PM
FORMELA JEAN FRANCOIS Director Apr 05, 2021 Sale $84.98 800 67,984 1,112,576 Apr 07, 2021, 02:14 PM
Rivera Jose E EVP, General Counsel Apr 01, 2021 Option Exercise $12.51 97,001 1,213,537 178,077 Apr 02, 2021, 08:42 PM
Rivera Jose E EVP, General Counsel Apr 01, 2021 Sale $82.46 50,455 4,160,559 176,112 Apr 02, 2021, 08:42 PM
FORMELA JEAN FRANCOIS Director Feb 26, 2021 Sale $60.29 501,945 30,262,716 1,113,376 Mar 01, 2021, 01:59 PM
Rivera Jose E EVP, General Counsel Feb 09, 2021 Option Exercise $18.30 21,000 384,195 129,409 Feb 09, 2021, 08:38 PM
Rivera Jose E EVP, General Counsel Feb 09, 2021 Sale $75.00 11,489 861,675 117,920 Feb 09, 2021, 08:38 PM
LEONARD JOHN M President and CEO Feb 09, 2021 Option Exercise $6.83 56,718 387,384 688,579 Feb 09, 2021, 08:36 PM
LEONARD JOHN M President and CEO Feb 05, 2021 Option Exercise $13.40 40,000 536,000 654,803 Feb 09, 2021, 08:36 PM
LEONARD JOHN M President and CEO Feb 09, 2021 Sale $75.00 28,043 2,103,225 660,536 Feb 09, 2021, 08:36 PM
LEONARD JOHN M President and CEO Feb 05, 2021 Sale $67.66 22,942 1,552,185 646,760 Feb 09, 2021, 08:36 PM
LEONARD JOHN M President and CEO Feb 03, 2021 Option Exercise $17.68 117,060 2,069,793 651,661 Feb 03, 2021, 09:39 PM
LEONARD JOHN M President and CEO Feb 01, 2021 Option Exercise $13.69 200,000 2,737,600 598,814 Feb 03, 2021, 09:39 PM
LEONARD JOHN M President and CEO Feb 03, 2021 Sale $72.54 67,856 4,922,490 614,803 Feb 03, 2021, 09:39 PM
LEONARD JOHN M President and CEO Feb 01, 2021 Sale $64.00 109,889 7,032,905 587,714 Feb 03, 2021, 09:39 PM
Rivera Jose E EVP, General Counsel Feb 01, 2021 Option Exercise $9.68 109,000 1,054,620 121,686 Feb 03, 2021, 09:38 PM
Rivera Jose E EVP, General Counsel Feb 01, 2021 Sale $63.99 54,659 3,497,903 115,069 Feb 03, 2021, 09:38 PM
Cohen Fred E Director Jan 20, 2021 Option Exercise $13.78 20,000 275,600 30,000 Jan 22, 2021, 04:22 PM
LEONARD JOHN M President and CEO Jan 05, 2021 Sale $55.86 6,239 348,511 475,488 Jan 05, 2021, 09:24 PM
SCHIERMEIER ANDREW EVP, Chief Operating Officer Jan 05, 2021 Sale $55.86 1,377 76,919 16,656 Jan 05, 2021, 08:58 PM
Rivera Jose E EVP, General Counsel Jan 05, 2021 Sale $55.86 2,078 116,077 51,990 Jan 05, 2021, 08:55 PM
SCHIERMEIER ANDREW EVP, Chief Operating Officer Dec 30, 2020 Option Exercise $13.48 1,500 20,220 12,673 Jan 04, 2021, 09:03 PM
KARSEN PERRY A Director Dec 17, 2020 Option Exercise $18.45 88,764 1,637,842 93,764 Dec 18, 2020, 04:29 PM
KARSEN PERRY A Director Dec 17, 2020 Sale $53.55 88,764 4,753,680 71,786 Dec 18, 2020, 04:29 PM
Rivera Jose E EVP, General Counsel Dec 01, 2020 Option Exercise $13.88 5,000 69,400 52,072 Dec 03, 2020, 06:42 PM
Rivera Jose E EVP, General Counsel Dec 01, 2020 Sale $38.21 3,364 128,525 50,487 Dec 03, 2020, 06:42 PM
LEONARD JOHN M President and CEO Nov 27, 2020 Option Exercise $16.17 35,000 566,100 487,352 Nov 27, 2020, 09:00 PM
LEONARD JOHN M President and CEO Nov 27, 2020 Sale $38.57 35,000 1,350,000 467,352 Nov 27, 2020, 09:00 PM
LEONARD JOHN M President and CEO Nov 25, 2020 Option Exercise $6.83 50,000 341,500 517,352 Nov 25, 2020, 08:02 PM
LEONARD JOHN M President and CEO Nov 25, 2020 Sale $36.00 50,000 1,800,000 467,352 Nov 25, 2020, 08:02 PM
LEONARD JOHN M President and CEO Nov 16, 2020 Option Exercise $14.58 20,000 291,600 487,352 Nov 18, 2020, 07:56 PM
LEONARD JOHN M President and CEO Nov 16, 2020 Sale $34.00 20,000 680,000 467,352 Nov 18, 2020, 07:56 PM
Rivera Jose E EVP, General Counsel Nov 18, 2020 Option Exercise $18.30 848 15,518 47,696 Nov 18, 2020, 07:55 PM
Rivera Jose E EVP, General Counsel Nov 16, 2020 Option Exercise $7.44 10,562 78,585 52,315 Nov 18, 2020, 07:55 PM
Rivera Jose E EVP, General Counsel Nov 18, 2020 Sale $35.00 624 21,840 47,072 Nov 18, 2020, 07:55 PM
Rivera Jose E EVP, General Counsel Nov 16, 2020 Sale $34.29 6,029 206,728 50,295 Nov 18, 2020, 07:55 PM
Rivera Jose E EVP, General Counsel Nov 04, 2020 Option Exercise $13.88 5,000 69,400 45,679 Nov 06, 2020, 04:41 PM
Rivera Jose E EVP, General Counsel Nov 04, 2020 Sale $28.00 3,364 94,192 42,315 Nov 06, 2020, 04:41 PM
LEONARD JOHN M President and CEO Nov 04, 2020 Option Exercise $6.83 50,000 341,500 517,352 Nov 06, 2020, 04:38 PM
LEONARD JOHN M President and CEO Nov 04, 2020 Sale $26.00 50,000 1,300,000 467,352 Nov 06, 2020, 04:38 PM
Rivera Jose E EVP, General Counsel Oct 15, 2020 Option Exercise $6.83 10,000 68,300 46,294 Oct 16, 2020, 08:58 PM
Rivera Jose E EVP, General Counsel Oct 15, 2020 Sale $24.20 5,615 135,883 40,835 Oct 16, 2020, 08:58 PM
LEONARD JOHN M President and CEO Oct 07, 2020 Option Exercise $6.83 5,000 34,150 472,352 Oct 09, 2020, 04:14 PM
LEONARD JOHN M President and CEO Oct 07, 2020 Sale $21.83 5,000 109,150 467,352 Oct 09, 2020, 04:14 PM
Rivera Jose E EVP, General Counsel Sep 15, 2020 Option Exercise $6.83 10,000 68,300 41,909 Sep 17, 2020, 04:55 PM
Rivera Jose E EVP, General Counsel Sep 15, 2020 Sale $21.04 5,615 118,140 36,294 Sep 17, 2020, 04:55 PM
LEONARD JOHN M. President and CEO Sep 01, 2020 Option Exercise $6.83 5,000 34,150 472,352 Sep 03, 2020, 04:15 PM
LEONARD JOHN M. President and CEO Sep 01, 2020 Sale $21.83 5,000 109,150 467,352 Sep 03, 2020, 04:15 PM
Rivera Jose E EVP, General Counsel Aug 18, 2020 Option Exercise $6.83 10,000 68,300 37,524 Aug 20, 2020, 04:13 PM
Rivera Jose E EVP, General Counsel Aug 18, 2020 Sale $21.00 5,615 117,915 31,909 Aug 20, 2020, 04:13 PM
LEONARD JOHN M. President and CEO Aug 06, 2020 Option Exercise $6.83 5,000 34,150 472,352 Aug 07, 2020, 07:29 PM
LEONARD JOHN M. President and CEO Aug 06, 2020 Sale $21.83 5,000 109,150 467,352 Aug 07, 2020, 07:29 PM
Rivera Jose E EVP, General Counsel Jul 15, 2020 Option Exercise $6.83 10,000 68,300 33,139 Jul 17, 2020, 04:18 PM
Rivera Jose E EVP, General Counsel Jul 15, 2020 Sale $22.70 5,615 127,461 27,524 Jul 17, 2020, 04:18 PM
LEONARD JOHN M. President and CEO Jul 01, 2020 Option Exercise $6.83 5,000 34,150 472,352 Jul 02, 2020, 04:10 PM
LEONARD JOHN M. President and CEO Jul 01, 2020 Sale $21.83 5,000 109,150 467,352 Jul 02, 2020, 04:10 PM
Rivera Jose E EVP, General Counsel Jun 16, 2020 Option Exercise $6.83 10,000 68,300 27,897 Jun 18, 2020, 05:00 PM
Rivera Jose E EVP, General Counsel Jun 16, 2020 Sale $21.00 5,615 117,915 22,282 Jun 18, 2020, 05:00 PM
LEONARD JOHN M. President and CEO Jun 03, 2020 Option Exercise $6.83 5,000 34,150 472,352 Jun 05, 2020, 05:18 PM
LEONARD JOHN M. President and CEO Jun 03, 2020 Sale $21.83 5,000 109,150 467,352 Jun 05, 2020, 05:18 PM
Rivera Jose E EVP, General Counsel May 26, 2020 Option Exercise $6.83 10,000 68,300 285,722 May 28, 2020, 05:23 PM
Rivera Jose E EVP, General Counsel May 26, 2020 Sale $21.21 5,615 119,094 280,107 May 28, 2020, 05:23 PM
SCHIERMEIER ANDREW EVP, Dev and Corp Strategy Mar 06, 2019 Buy $15.72 7,500 117,875 7,500 Mar 12, 2019, 04:38 PM
Cohen Fred E Director Mar 01, 2019 Option Exercise $16.89 10,000 168,936 10,000 Mar 05, 2019, 12:00 AM
FORMELA JEAN FRANCOIS Director Jul 16, 2018 Sale $31.17 6,686 208,397 1,402 Jul 18, 2018, 08:40 AM
FORMELA JEAN FRANCOIS Director Jun 19, 2018 Sale $27.96 6,686 186,908 1,400 Jun 20, 2018, 12:03 PM
FORMELA JEAN FRANCOIS Director May 16, 2018 Sale $25.04 6,686 167,389 0 May 17, 2018, 10:47 AM
LEONARD JOHN M. President and CEO May 14, 2018 Sale $24.00 8,400 201,600 0 May 15, 2018, 08:43 PM
Bell Graeme EVP, Chief Financial Officer Mar 28, 2018 Option Exercise $13.48 8,000 107,840 21,400 Mar 30, 2018, 10:20 AM
DORSA CAROLINE Director Mar 23, 2018 Option Exercise $24.05 410 9,860 5,410 Mar 26, 2018, 05:12 PM
FORMELA JEAN FRANCOIS Director Mar 20, 2018 Sale $23.87 39,245 936,743 36,628 Mar 22, 2018, 01:43 PM
Caribou Biosciences, Inc. 10% Owner Jan 29, 2018 Sale $26.78 550,645 14,746,273 3,994,355 Jan 30, 2018, 05:28 PM
Novartis Institutes for BioMedical Research, Inc. 10% Owner Dec 12, 2017 Sale $18.30 1,523,000 27,870,899 4,129,903 Dec 14, 2017, 12:19 PM
Bermingham Nessan President & CEO Dec 06, 2017 Sale $20.34 111,500 2,268,001 696,000 Dec 08, 2017, 05:27 PM
Bermingham Nessan President & CEO Dec 08, 2017 Sale $20.82 94,143 1,960,151 458,250 Dec 08, 2017, 05:27 PM
Bermingham Nessan President & CEO Dec 07, 2017 Sale $21.14 131,140 2,771,867 579,959 Dec 08, 2017, 05:27 PM
Bell Graeme EVP, Chief Financial Officer Nov 03, 2017 Option Exercise $22.04 5,000 110,217 13,400 Nov 03, 2017, 11:54 AM
FORMELA JEAN FRANCOIS Director Jul 11, 2017 Sale $16.07 80,000 1,285,560 3,579,788 Jul 11, 2017, 05:40 PM
FORMELA JEAN FRANCOIS Director Jul 10, 2017 Sale $16.17 40,000 646,888 3,659,788 Jul 11, 2017, 05:40 PM
FORMELA JEAN FRANCOIS Director Jul 07, 2017 Sale $16.77 30,000 502,992 3,699,788 Jul 11, 2017, 05:40 PM
Atlas Venture Fund IX, L.P. 10% Owner Jul 11, 2017 Sale $16.07 80,000 1,285,560 3,579,788 Jul 11, 2017, 05:37 PM
Atlas Venture Fund IX, L.P. 10% Owner Jul 10, 2017 Sale $16.17 40,000 646,888 3,659,788 Jul 11, 2017, 05:37 PM
Atlas Venture Fund IX, L.P. 10% Owner Jul 07, 2017 Sale $16.77 30,000 502,992 3,699,788 Jul 11, 2017, 05:37 PM
DORSA CAROLINE Director Jun 02, 2017 Option Exercise $12.42 5,000 62,100 5,000 Jun 05, 2017, 08:03 AM
KARSEN PERRY A Director Jun 01, 2017 Option Exercise $11.98 5,000 59,925 5,000 Jun 05, 2017, 08:01 AM
Bell Graeme EVP, Chief Financial Officer Jun 02, 2017 Option Exercise $12.37 8,400 103,938 8,400 Jun 05, 2017, 07:59 AM
LEONARD JOHN M. EVP, R&D Jun 01, 2017 Option Exercise $12.06 8,400 101,322 8,400 Jun 05, 2017, 07:55 AM
Bermingham Nessan President & CEO Jun 01, 2017 Option Exercise $11.95 8,400 100,379 795,033 Jun 05, 2017, 07:53 AM
Atlas Venture Associates IX, L.P. 10% Owner Mar 10, 2017 Sale $14.06 5,504 77,410 0 Mar 13, 2017, 10:39 AM
Atlas Venture Associates IX, L.P. 10% Owner Mar 09, 2017 Sale $13.85 15,628 216,432 5,504 Mar 13, 2017, 10:39 AM
FORMELA JEAN FRANCOIS Director Mar 09, 2017 Sale $13.85 15,628 216,432 5,504 Mar 13, 2017, 10:34 AM
FORMELA JEAN FRANCOIS Director Mar 10, 2017 Sale $14.06 5,504 77,410 0 Mar 13, 2017, 10:34 AM
ORBIMED ADVISORS LLC Director May 11, 2016 Buy $18.00 250,000 4,500,000 2,662,180 May 13, 2016, 04:58 PM
Temasek Holdings (Private) Ltd 10% Owner May 11, 2016 Buy $18.00 300,000 5,400,000 790,527 May 13, 2016, 06:15 AM
Novartis Institutes for BioMedical Research, Inc. 10% Owner May 11, 2016 Buy $18.00 277,777 4,999,986 5,573,658 May 11, 2016, 06:57 PM
GORDON CARL L Director May 11, 2016 Buy $18.00 250,000 4,500,000 2,662,180 May 11, 2016, 06:36 PM
BAKER BROS. ADVISORS LP Former 10% owner May 11, 2016 Buy $18.00 200,000 3,600,000 976,214 May 11, 2016, 04:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
LEONARD JOHN M President and CEO 01/01/2022 279,852
Sepp-Lorenzino Laura EVP, Chief Scientific Officer 01/01/2022 128,863
Lebwohl David EVP, Chief Medical Officer 01/01/2022 117,964
Goddard Glenn EVP, Chief Financial Officer 01/01/2022 113,699
Lebwohl David EVP, Chief Medical Officer 11/05/2021 30,288
Lebwohl David EVP, Chief Medical Officer 11/05/2021 318,535
Lebwohl David EVP, Chief Medical Officer 10/14/2021 30,288
Lebwohl David EVP, Chief Medical Officer 10/14/2021 308,249
Crowley John F Director 10/11/2021 47,075
Crowley John F Director 10/11/2021 298,875
Crowley John F Director 10/05/2021 188,300
Crowley John F Director 10/05/2021 1,305,391
Lebwohl David EVP, Chief Medical Officer 09/24/2021 99,988
Lebwohl David EVP, Chief Medical Officer 09/21/2021 30,288
Lebwohl David EVP, Chief Medical Officer 09/21/2021 359,544
Goddard Glenn EVP, Chief Financial Officer 09/07/2021 50,768
Goddard Glenn EVP, Chief Financial Officer 09/07/2021 627,178
LEONARD JOHN M President and CEO 08/31/2021 551,605
LEONARD JOHN M President and CEO 08/30/2021 552,031
LEONARD JOHN M President and CEO 09/01/2021 967,000
LEONARD JOHN M President and CEO 08/31/2021 5,864,115
LEONARD JOHN M President and CEO 08/30/2021 6,051,353
LEONARD JOHN M President and CEO 09/01/2021 7,604,950
Sepp-Lorenzino Laura EVP, Chief Scientific Officer 08/30/2021 1,359,300
Sepp-Lorenzino Laura EVP, Chief Scientific Officer 08/30/2021 15,018,055
Lebwohl David EVP, Chief Medical Officer 08/30/2021 30,288
Lebwohl David EVP, Chief Medical Officer 08/30/2021 379,300
Goddard Glenn EVP, Chief Financial Officer 08/30/2021 100,204
Goddard Glenn EVP, Chief Financial Officer 08/31/2021 469,374
Goddard Glenn EVP, Chief Financial Officer 08/30/2021 810,082
Goddard Glenn EVP, Chief Financial Officer 08/31/2021 3,973,456
LEONARD JOHN M President and CEO 08/23/2021 363,663
LEONARD JOHN M President and CEO 08/23/2021 4,125,416
LEONARD JOHN M President and CEO 08/19/2021 303,939
LEONARD JOHN M President and CEO 08/19/2021 3,431,398
Lebwohl David EVP, Chief Medical Officer 08/09/2021 30,288
Lebwohl David EVP, Chief Medical Officer 08/09/2021 393,720
Sepp-Lorenzino Laura EVP, Chief Scientific Officer 08/04/2021 348,400
Sepp-Lorenzino Laura EVP, Chief Scientific Officer 08/04/2021 3,594,357
Goddard Glenn EVP, Chief Financial Officer 08/05/2021 385,400
Goddard Glenn EVP, Chief Financial Officer 08/05/2021 3,021,056
FORMELA JEAN FRANCOIS Director 04/29/2021 385,546
FORMELA JEAN FRANCOIS Director 04/28/2021 11,287,893
FORMELA JEAN FRANCOIS Director 04/27/2021 18,125,992
FORMELA JEAN FRANCOIS Director 04/26/2021 68,454
LEONARD JOHN M President and CEO 04/13/2021 289,506
FORMELA JEAN FRANCOIS Director 04/05/2021 67,984
Rivera Jose E EVP, General Counsel 04/01/2021 1,213,537
Rivera Jose E EVP, General Counsel 04/01/2021 4,160,559
FORMELA JEAN FRANCOIS Director 02/26/2021 30,262,716
Rivera Jose E EVP, General Counsel 02/09/2021 384,195
Rivera Jose E EVP, General Counsel 02/09/2021 861,675
LEONARD JOHN M President and CEO 02/09/2021 387,384
LEONARD JOHN M President and CEO 02/05/2021 536,000
LEONARD JOHN M President and CEO 02/09/2021 2,103,225
LEONARD JOHN M President and CEO 02/05/2021 1,552,185
LEONARD JOHN M President and CEO 02/03/2021 2,069,793
LEONARD JOHN M President and CEO 02/01/2021 2,737,600
LEONARD JOHN M President and CEO 02/03/2021 4,922,490
LEONARD JOHN M President and CEO 02/01/2021 7,032,905
Rivera Jose E EVP, General Counsel 02/01/2021 1,054,620
Rivera Jose E EVP, General Counsel 02/01/2021 3,497,903
Cohen Fred E Director 01/20/2021 275,600
LEONARD JOHN M President and CEO 01/05/2021 348,511
SCHIERMEIER ANDREW EVP, Chief Operating Officer 01/05/2021 76,919
Rivera Jose E EVP, General Counsel 01/05/2021 116,077
SCHIERMEIER ANDREW EVP, Chief Operating Officer 12/30/2020 20,220
KARSEN PERRY A Director 12/17/2020 1,637,842
KARSEN PERRY A Director 12/17/2020 4,753,680
Rivera Jose E EVP, General Counsel 12/01/2020 69,400
Rivera Jose E EVP, General Counsel 12/01/2020 128,525
LEONARD JOHN M President and CEO 11/27/2020 566,100
LEONARD JOHN M President and CEO 11/27/2020 1,350,000
LEONARD JOHN M President and CEO 11/25/2020 341,500
LEONARD JOHN M President and CEO 11/25/2020 1,800,000
LEONARD JOHN M President and CEO 11/16/2020 291,600
LEONARD JOHN M President and CEO 11/16/2020 680,000
Rivera Jose E EVP, General Counsel 11/18/2020 15,518
Rivera Jose E EVP, General Counsel 11/16/2020 78,585
Rivera Jose E EVP, General Counsel 11/18/2020 21,840
Rivera Jose E EVP, General Counsel 11/16/2020 206,728
Rivera Jose E EVP, General Counsel 11/04/2020 69,400
Rivera Jose E EVP, General Counsel 11/04/2020 94,192
LEONARD JOHN M President and CEO 11/04/2020 341,500
LEONARD JOHN M President and CEO 11/04/2020 1,300,000
Rivera Jose E EVP, General Counsel 10/15/2020 68,300
Rivera Jose E EVP, General Counsel 10/15/2020 135,883
LEONARD JOHN M President and CEO 10/07/2020 34,150
LEONARD JOHN M President and CEO 10/07/2020 109,150
Rivera Jose E EVP, General Counsel 09/15/2020 68,300
Rivera Jose E EVP, General Counsel 09/15/2020 118,140
LEONARD JOHN M. President and CEO 09/01/2020 34,150
LEONARD JOHN M. President and CEO 09/01/2020 109,150
Rivera Jose E EVP, General Counsel 08/18/2020 68,300
Rivera Jose E EVP, General Counsel 08/18/2020 117,915
LEONARD JOHN M. President and CEO 08/06/2020 34,150
LEONARD JOHN M. President and CEO 08/06/2020 109,150
Rivera Jose E EVP, General Counsel 07/15/2020 68,300
Rivera Jose E EVP, General Counsel 07/15/2020 127,461
LEONARD JOHN M. President and CEO 07/01/2020 34,150
LEONARD JOHN M. President and CEO 07/01/2020 109,150
Rivera Jose E EVP, General Counsel 06/16/2020 68,300
Rivera Jose E EVP, General Counsel 06/16/2020 117,915
LEONARD JOHN M. President and CEO 06/03/2020 34,150
LEONARD JOHN M. President and CEO 06/03/2020 109,150
Rivera Jose E EVP, General Counsel 05/26/2020 68,300
Rivera Jose E EVP, General Counsel 05/26/2020 119,094
SCHIERMEIER ANDREW EVP, Dev and Corp Strategy 03/06/2019 117,875
Cohen Fred E Director 03/01/2019 168,936
FORMELA JEAN FRANCOIS Director 07/16/2018 208,397
FORMELA JEAN FRANCOIS Director 06/19/2018 186,908
FORMELA JEAN FRANCOIS Director 05/16/2018 167,389
LEONARD JOHN M. President and CEO 05/14/2018 201,600
Bell Graeme EVP, Chief Financial Officer 03/28/2018 107,840
DORSA CAROLINE Director 03/23/2018 9,860
FORMELA JEAN FRANCOIS Director 03/20/2018 936,743
Caribou Biosciences, Inc. 10% Owner 01/29/2018 14,746,273
Novartis Institutes for BioMedical Research, Inc. 10% Owner 12/12/2017 27,870,899
Bermingham Nessan President & CEO 12/06/2017 2,268,001
Bermingham Nessan President & CEO 12/08/2017 1,960,151
Bermingham Nessan President & CEO 12/07/2017 2,771,867
Bell Graeme EVP, Chief Financial Officer 11/03/2017 110,217
FORMELA JEAN FRANCOIS Director 07/11/2017 1,285,560
FORMELA JEAN FRANCOIS Director 07/10/2017 646,888
FORMELA JEAN FRANCOIS Director 07/07/2017 502,992
Atlas Venture Fund IX, L.P. 10% Owner 07/11/2017 1,285,560
Atlas Venture Fund IX, L.P. 10% Owner 07/10/2017 646,888
Atlas Venture Fund IX, L.P. 10% Owner 07/07/2017 502,992
DORSA CAROLINE Director 06/02/2017 62,100
KARSEN PERRY A Director 06/01/2017 59,925
Bell Graeme EVP, Chief Financial Officer 06/02/2017 103,938
LEONARD JOHN M. EVP, R&D 06/01/2017 101,322
Bermingham Nessan President & CEO 06/01/2017 100,379
Atlas Venture Associates IX, L.P. 10% Owner 03/10/2017 77,410
Atlas Venture Associates IX, L.P. 10% Owner 03/09/2017 216,432
FORMELA JEAN FRANCOIS Director 03/09/2017 216,432
FORMELA JEAN FRANCOIS Director 03/10/2017 77,410
ORBIMED ADVISORS LLC Director 05/11/2016 4,500,000
Temasek Holdings (Private) Ltd 10% Owner 05/11/2016 5,400,000
Novartis Institutes for BioMedical Research, Inc. 10% Owner 05/11/2016 4,999,986
GORDON CARL L Director 05/11/2016 4,500,000
BAKER BROS. ADVISORS LP Former 10% owner 05/11/2016 3,600,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
1.68%
1Q
12/31/2021
06/30/2021
4.76%
2Q
12/31/2021
09/30/2020
30.76%
5Q
12/31/2021
03/31/2020
40.41%
7Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
1.68%
1Q
06/30/2021
4.76%
2Q
09/30/2020
30.76%
5Q
03/31/2020
40.41%
7Q
Load More